Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
TransPacific Venture Partners (TPV) is a venture capital firm based in Taipei City, Taiwan, focused on early-stage medical technology ventures. The firm was founded by partners with extensive backgrounds in medicine, engineering, and venture investing. TPV invests between $500,000 and $3 million and maintains reserves for follow-on financing rounds.
TPV invests in early-stage medical technology companies, typically at the pre-seed, seed, and seed-plus stages. The firm targets investments ranging from $500,000 to $3 million, aiming to identify unmet needs in healthcare and support the development of impactful products in the medical devices sector.
Email contact@transpacific-vc.com with your deck to pitch TransPacific Venture Partners.
Yes, TPV often leads investment rounds in the companies they back, providing not just capital but also strategic guidance.
TPV maintains reserves for subsequent financing rounds, allowing them to support their portfolio companies as they grow.
Specific fund size details are not disclosed, but TPV invests between $500,000 and $3 million in early-stage ventures.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.